About
Pioneering a novel class of precision biologics for infection control in cancer care and beyond
Obulytix is dedicated to combating the escalating global crisis of antimicrobial resistance (AMR) — a major threat undermining even the most advanced medical therapies.
By harnessing the power of synthetic biology, we are developing a novel class of precision biologics designed to selectively target and eliminate drug-resistant bacterial pathogens.
Our Origins
Obulytix was founded in 2023 as a spin-off from Ghent University and KU Leuven, built on over two decades of pioneering research in lysin engineering. The company was launched following a successful seed round, with the support from leading investors including Boehringer Ingelheim Venture Fund, Qbic Fund, and Gemma-Frisius Fund.
By combining deep academic expertise with a proprietary technology platform, Obulytix is purpose-built to tackle multidrug-resistant Gram-negative bacterial infections—one of the most pressing challenges in infectious disease today.
Founding member
Operations Lead
10+ years synthetic biology and protein engineering experience
Led by an experienced team of complementary talents
Board of Directors
With deep experience in biotech innovation, company building and venture capital, our Board of Directors supports us in scaling breakthrough science into real-world impact.
Lisa Patel, PhD
Independent Chair
Philipp Müller, PhD
Boehringer Ingelheim Venture Fund
Cédric Van Nevel
Qbic Fund
Bram Perdu, PhD
Gemma-Frisius Fund
Dominic De Groote, PhD
UGent, KU Leuven
Yves Briers, Prof PhD
Scientific Founder
Expert Advisors
Our advisors are internationally recognized leaders in lysin research, protein engineering and infectious disease research and development. Their expertise drives our innovation and guides our mission to transform the future of antimicrobial therapy.
Yves Briers, Prof PhD
Senior Scientific Advisor
Dr. Jens Wuerthner, MD PhD FFPM
Senior Scientific & Clinical Advisor
Dr. Kenny Simmen, PhD
Senior Scientific & Business Advisor
Our partners
_1.png)
